On October 7, 2013, the S. Ct. denied cert., ending Intema’s appeal of the Fed. Cir. decision that its patent claims on a method to determine the level of risk of a Down syndrome pregnancy were not patent-eligible subject matter under s. 101. (Supreme Court No. 12-1372). Although a high court ruling on the patent-eligibility [...]
The post Cert. Denied in Intema Ltd. v. PerkinElmer, Inc. appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.